Program
Abatacept
Also written as “Belatacept”, “abatacept” and “Abatacept (BMS-188667)”.
Its studies are mostly in Arthritis, Rheumatoid · Arthritis, Juvenile · Psoriasis · Arthritis, Psoriatic · Lupus Nephritis, led by 3 companies.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Bristol-Myers Squibb | 652 open or running | phase 4since Dec 19, 2012 | May 3, 2002 | Dec 30, 2032phase 3 · NCT04877288 |
| Simcere Pharmaceutical Group | 20 open or running | phase 3since Mar 10, 2016 | Mar 10, 2016 | none ahead |
| Amneal Pharmaceuticals | 10 open or running | phase 1since Jan 31, 2025 | Jan 31, 2025 | none ahead |
Also a collaborator on its studies: Ono Pharmaceutical.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 45 studies since Jun 30, 2005.
- May 12, 2014Phase 2 study in Kidney TransplantationBristol-Myers Squibb · NCT02137239 · 58 enrolled · United States, Argentina
- Jul 20, 2015Phase 3 study in Arthritis, RheumatoidBristol-Myers Squibb · NCT02504268 · 994 enrolled · United States, Argentina, Australia and more
- Oct 29, 2015Phase 2 study in Nephrotic SyndromeBristol-Myers Squibb · NCT02592798 · 36 enrolled · United States
- Mar 10, 2016Simcere Pharmaceutical Group's first study: phase 3 study in Arthritis, RheumatoidNew to Simcere Pharmaceutical GroupSimcere Pharmaceutical Group · NCT02722694 · 360 enrolled · China
- Jun 12, 2016Phase 1 study in Arthritis, RheumatoidSimcere Pharmaceutical Group · NCT02805010 · 22 enrolled
- Sep 23, 2016Phase 3 study in Sjogrens DiseaseBristol-Myers Squibb · NCT02915159 · 250 enrolled · United States, Argentina, Australia and more
- Jun 14, 2017Phase 3 study in Giant Cell ArteritisBristol-Myers Squibb · NCT03192969 · United States, Australia, Austria and more
- Dec 13, 2017Phase 1 study in Healthy VolunteersBristol-Myers Squibb · NCT03375138 · 84 enrolled · United States
- Oct 18, 2018Phase 1 study in Arthritis, RheumatoidBristol-Myers Squibb · NCT03714022 · 140 enrolled · United States
- Nov 28, 2019Phase 2 study in Autoimmune DiseasesBristol-Myers Squibb · NCT04186871 · 119 enrolled · United States, Argentina, Belgium and more
- Jul 14, 2020Phase 2 study in COVID-19Bristol-Myers Squibb · NCT04472494 · 61 enrolled · United States, Puerto Rico
- May 3, 20212 phase 3 studiesBristol-Myers Squibb · NCT04877288, NCT04909801
- Aug 1, 2023Phase 1 study in Healthy ParticipantsBristol-Myers Squibb · NCT05981976 · 174 enrolled · United States
- Jan 31, 2025Amneal Pharmaceuticals's first study: phase 1 study in Arthritis, RheumatoidNew to Amneal PharmaceuticalsAmneal Pharmaceuticals · NCT06929039 · 300 enrolled · Canada
Ahead
- Dec 30, 2032Primary completion: phase 3 study in Renal Allograft RecipientsBristol-Myers Squibb · NCT04877288
TargetBeta
“T-lymphocyte activation antigen CD86 inhibitor; T-lymphocyte activation antigen CD80 inhibitor”ChEMBL 37, by rule
Studies
The newest 60 of 68 led by companies developing it. Each opens its study page. Every study on its drug page →
| Study | Phase | Status | Led by | Primary completion | Size |
|---|---|---|---|---|---|
| NCT06929039Arthritis, Rheumatoid · Canada | 1 | Completed | Amneal Pharmaceuticals | Oct 16, 2024 | 300 |
| NCT05981976Healthy Participants · United States | 1 | Completed | Bristol-Myers Squibb | Dec 14, 2023 | 174 |
| NCT04909801Arthritis, Rheumatoid · United States, Argentina, Australia and more | 3 | Active, not recruiting | Bristol-Myers Squibb | Jun 14, 2023 | 338 |
| NCT04877288Renal Allograft Recipients · United States, Argentina, Belgium and more | 3 | Recruiting | Bristol-Myers Squibb | Dec 30, 2032 | 102 |
| NCT04472494COVID-19 · United States, Puerto Rico | 2 | Terminated | Bristol-Myers Squibb | Aug 12, 2021 | 61 |
| NCT04186871Autoimmune Diseases · United States, Argentina, Belgium and more | 2 | Completed | Bristol-Myers Squibb | Dec 5, 2022 | 119 |
| NCT03714022Arthritis, Rheumatoid · United States | 1 | Completed | Bristol-Myers Squibb | Apr 2, 2019 | 140 |
| NCT03375138Healthy Volunteers · United States | 1 | Completed | Bristol-Myers Squibb | May 8, 2018 | 84 |
| NCT03192969Giant Cell Arteritis · United States, Australia, Austria and more | 3 | Withdrawn | Bristol-Myers Squibb | Jun 7, 2020 | 0 |
| NCT02915159Sjogrens Disease · United States, Argentina, Australia and more | 3 | Completed | Bristol-Myers Squibb | Aug 7, 2018 | 250 |
| NCT02805010Arthritis, Rheumatoid | 1 | UNKNOWN | Simcere Pharmaceutical Group | Feb 2017 | 22 |
| NCT02722694Arthritis, Rheumatoid · China | 3 | UNKNOWN | Simcere Pharmaceutical Group | Jun 2017 | 360 |
| NCT02592798Nephrotic Syndrome · United States | 2 | Completed | Bristol-Myers Squibb | Jan 28, 2020 | 36 |
| NCT02504268Arthritis, Rheumatoid · United States, Argentina, Australia and more | 3 | Completed | Bristol-Myers Squibb | Jan 16, 2017 | 994 |
| NCT02137239Kidney Transplantation · United States, Argentina | 2 | Completed | Bristol-Myers Squibb | May 2, 2019 | 58 |
| NCT01890473Arthritis, Rheumatoid · United States, Argentina, Mexico and more | 1 | Completed | Bristol-Myers Squibb | Nov 2014 | 356 |
| NCT01860976Arthritis, Psoriatic · United States, Argentina, Brazil and more | 3 | Completed | Bristol-Myers Squibb | Jul 14, 2015 | 489 |
| NCT01844518Active Polyarticular Juvenile Idiopathic Arthritis · United States, Argentina, Belgium and more | 3 | Completed | Bristol-Myers Squibb | Mar 12, 2015 | 219 |
| NCT01835470Arthritis, Juvenile · Japan | 3 | Completed | Bristol-Myers Squibb | Nov 24, 2015 | 23 |
| NCT01844895Arthritis, Rheumatoid | 3 | Completed | Bristol-Myers Squibb | Jul 2014 | 120 |
| NCT01820572Kidney Transplantation · United States, Argentina, Austria and more | 3 | Completed | Bristol-Myers Squibb | Oct 24, 2019 | 446 |
| NCT01791491Kidney Transplant · United States | 2 | Completed | Bristol-Myers Squibb | Dec 6, 2016 | 16 |
| NCT01766050Transplant Rejection · United States | 4 | Completed | Bristol-Myers Squibb | Apr 2013 | 45 |
| NCT01758198Arthritis, Rheumatoid · Japan | 4 | Completed | Bristol-Myers Squibb | Dec 26, 2016 | 405 |
| NCT01714817Lupus Nephritis · United States, Argentina, Australia and more | 3 | Terminated | Bristol-Myers Squibb | Nov 21, 2016 | 695 |
| NCT01439204Arthritis, Rheumatoid · United States | 1 | Completed | Bristol-Myers Squibb | Feb 2012 | 223 |
| NCT01221636Arthritis, Rheumatoid · United States | 1 | Withdrawn | Bristol-Myers Squibb | Feb 2011 | 0 |
| NCT01142726Arthritis, Rheumatoid · United States, Australia, Belgium and more | 3 | Completed | Bristol-Myers Squibb | Sep 2013 | 511 |
| NCT00989235Arthritis, Rheumatoid | 3 | Completed | Bristol-Myers Squibb | Oct 2009 | 108 |
| NCT00929864Arthritis, Rheumatoid · United States, Argentina, Canada and more | 3 | Completed | Bristol-Myers Squibb | Oct 2011 | 869 |
| NCT00767325Arthritis, Rheumatoid · Denmark, France, Germany and more | 3 | Completed | Bristol-Myers Squibb | Oct 2011 | 104 |
| NCT00705367Lupus Nephritis · China | 1 | Completed | Bristol-Myers Squibb | Jan 2009 | 13 |
| NCT00663702Arthritis, Rheumatoid · United States, Canada, Mexico | 3 | Completed | Bristol-Myers Squibb | Dec 2009 | 123 |
| NCT00578448Renal Transplantation · United States, Argentina, Mexico | 2 | Completed | Bristol-Myers Squibb | Mar 2009 | 14 |
| NCT00569803Transplantation · United States | 1 | Completed | Bristol-Myers Squibb | Aug 2008 | 153 |
| NCT00559585Arthritis, Rheumatoid · United States, Argentina, Australia and more | 3 | Completed | Bristol-Myers Squibb | Nov 2009 | 2,492 |
| NCT00547521Arthritis, Rheumatoid · United States, Australia, Mexico and more | 3 | Completed | Bristol-Myers Squibb | Dec 2008 | 119 |
| NCT00534313Arthritis, Psoriatic · United States, Argentina, Australia and more | 2 | Terminated | Bristol-Myers Squibb | Dec 2008 | 191 |
| NCT00533897Arthritis, Rheumatoid · United States, Argentina, Canada and more | 3 | Completed | Bristol-Myers Squibb | Dec 2008 | 270 |
| NCT00484289Arthritis, Rheumatoid · Japan | 3 | Completed | Bristol-Myers Squibb | Dec 2010 | 217 |
| NCT00455013Disorder Related to Renal Transplantation · United States, Italy, Spain | 2 | Completed | Bristol-Myers Squibb | Oct 2008 | 93 |
| NCT00430677Lupus Erythematosus, Systemic · United States, Argentina, Australia and more | 3 | Terminated | Bristol-Myers Squibb | Sep 2010 | 423 |
| NCT00420199Active Rheumatoid Arthritis · Belgium, Germany, Netherlands and more | 3 | Completed | Bristol-Myers Squibb | Aug 2009 | 50 |
| NCT00410410Colitis, Ulcerative · United States, Australia, Belgium and more | 3 | Completed | Bristol-Myers Squibb | Jun 2009 | 591 |
| NCT00409838Arthritis, Rheumatoid · Korea, Republic of | 3 | Completed | Bristol-Myers Squibb | Jul 2008 | 113 |
| NCT00406653Crohn Disease · United States, Australia, Belgium and more | 3 | Terminated | Bristol-Myers Squibb | Nov 2009 | 451 |
| NCT00402168Renal Transplant · United States, Argentina, Australia and more | 2 | Completed | Bristol-Myers Squibb | Jun 2009 | 173 |
| NCT00345748Arthritis, Rheumatoid · Japan | 2 | Completed | Bristol-Myers Squibb | Nov 2007 | 194 |
| NCT00306878Psoriasis Vulgaris · United States | 1 | Completed | Bristol-Myers Squibb | May 1997 | 45 |
| NCT00287547Psoriasis Vulgaris · United States | 2 | Completed | Bristol-Myers Squibb | Jan 1998 | 144 |
| NCT00279734Arthritis, Rheumatoid · United States | 1 | Completed | Bristol-Myers Squibb | Jan 2005 | 80 |
| NCT00277225Psoriasis Vulgaris · United States | 1 | Completed | Bristol-Myers Squibb | Jun 1996 | 32 |
| NCT00277199Healthy Subjects · United Kingdom | 1 | Completed | Bristol-Myers Squibb | Dec 2002 | 30 |
| NCT00254293Arthritis, Rheumatoid · United States | 2 | Completed | Bristol-Myers Squibb | May 2007 | 87 |
| NCT00162279Arthritis, Rheumatoid · United States | 2 | Completed | Bristol-Myers Squibb | Feb 2007 | 141 |
| NCT00162266Arthritis, Rheumatoid · United States, Argentina, Australia and more | 2 | Completed | Bristol-Myers Squibb | Sep 2009 | 524 |
| NCT00162201Arthritis, Rheumatoid · United Kingdom | 1 | Completed | Bristol-Myers Squibb | Apr 2005 | 16 |
| NCT00122382Arthritis, Rheumatoid · United States, Australia, Belgium and more | 3 | Completed | Bristol-Myers Squibb | Feb 2008 | 1,052 |
| NCT00124982Arthritis, Rheumatoid · United States, Belgium, Czech Republic and more | 3 | Completed | Bristol-Myers Squibb | Aug 2009 | 1,286 |
| NCT00124449Arthritis, Rheumatoid · United States, Australia, Belgium and more | 2 | Completed | Bristol-Myers Squibb | May 2007 | 56 |
How it is read
Names in the registry
- “Abatacept”, 53 entries
- “Belatacept”, 9 entries
- “abatacept”, 4 entries
- “Abatacept (BMS-188667)”, 4 entries
- “belatacept”, 2 entries
Conditions, from the studies’ own filings
- Arthritis, Rheumatoid, 35 studies
- Arthritis, Juvenile, 3 studies
- Psoriasis, 3 studies
- Arthritis, Psoriatic, 2 studies
- Lupus Nephritis, 2 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.